Manufacturing


  • A U.S. flag flying above a building showing a sign with the word Lilly written in red.
    Image attribution tooltip
    Scott Olson via Getty Images
    Image attribution tooltip

    Lilly to pour $5B more into expanding Zepbound, Mounjaro production

    The planned spending on new facilities in Lebanon, Indiana, brings its total commitment to the site to $9 billion, the largest single manufactuing investment in company history.

    By May 24, 2024
  • Robert Califf
    Image attribution tooltip
    Anna Moneymaker via Getty Images
    Image attribution tooltip

    As drug shortages reach record highs, regulators weigh next steps

    With many chemotherapy and ADHD drugs stuck in stubbornly short supply, several agencies are looking for new solutions.

    By Kelly Bilodeau • May 6, 2024
  • A Lilly sign is seen on the side of a building viewed through pine trees
    Image attribution tooltip
    jetcityimage via Getty Images
    Image attribution tooltip
    Obesity drugs

    Lilly counts on manufacturing scale-up to unstick obesity drug supply

    Increasing the production capacity for Zepbound and Mounjaro is “the most ambitious expansion plan in our company’s history,” said CEO David Ricks.

    By April 30, 2024
  • A digital image of chemicals in bottles and molecules
    Image attribution tooltip
    Permission granted by Asymchem
    Image attribution tooltip
    Sponsored by Asymchem

    Sustainability in pharmaceutical manufacturing: a CDMO’s contribution

    Consideration of sustainability early in process development, throughout the entire development cycle, and across the entire supply chain must also become common practice.

    By Mark McLaws, Ph.D. – Vice President CMC & Development, Asymchem • April 29, 2024
  • A U.S. flag flying above a building showing a sign with the word Lilly written in red.
    Image attribution tooltip
    Scott Olson via Getty Images
    Image attribution tooltip

    Lilly to buy injectable drug plant in manufacturing ramp-up

    The acquisition of a Nexus Pharmaceuticals facility in Wisconsin could help Lilly better meet demand for injectable medicines, like those it makes for diabetes and obesity.

    By April 22, 2024
  • An illustration of immune system T cells attacking cancer cells.
    Image attribution tooltip
    Meletios Verras via Getty Images
    Image attribution tooltip

    Bristol Myers taps startup to boost cell therapy production

    A partnership with Cellares, worth up to $380 million, is meant to help Bristol Myers speed and scale manufacture of CAR-T treatments for cancer.

    By April 22, 2024
  • Cleanroom image
    Image attribution tooltip
    Permission granted by PHC Corporation of North America
    Image attribution tooltip
    Sponsored by PHC Corporation of North America (PHCNA)

    Keeping cleanrooms clean: Choosing the right laboratory equipment is key

     Because live cell and tissue products are sensitive to contamination from microorganisms, viral particles or other  impurities, research and manufacturing involving these materials needs to be conducted in a cleanroom environment.

    April 15, 2024
  • Image attribution tooltip
    Novartis
    Image attribution tooltip

    Novartis pauses enrollment in some Kisqali trials to fix manufacturing

    The company said the pause is necessary to meet regulatory limits on nitrosamine, but added it will not affect commercial supply nor regulatory review of the drug in early breast cancer.

    By April 10, 2024
  • The East facade of the Capitol Building in Washington DC.
    Image attribution tooltip
    dkfielding via Getty Images
    Image attribution tooltip

    BIO changes stance, backs bill to limit China’s role in US biotech

    Pressed by lawmakers, the lobbying group is also “taking steps” to end its relationship with WuXi-AppTec, a major contract manufacturer to the biopharmaceutical industry.

    By March 14, 2024
  • Animated image of medical professionals talking and two small life images of a manufacture and pharmaceutical pills
    Image attribution tooltip
    Permission granted by Asymchem
    Image attribution tooltip
    Sponsored by Asymchem

    Advanced technologies in unlocking the future of drug manufacturing

    Innovative technologies, such as flow chemistry and biocatalysis, are achieving not only sustainability goals but also unprecedented levels of quality and efficiency.

    By Jon Brice, PhD • March 11, 2024
  • Image attribution tooltip
    Thomas Lohnes via Getty Images
    Image attribution tooltip

    BioNTech partners with Autolus to boost cell therapy manufacturing

    The German biotech will invest $200 million in Autolus — funds that, along with a $50 million fee, give it licensing options and access to supply infrastructure.

    By Kristin Jensen • Feb. 8, 2024
  • Image attribution tooltip
    Lisa LaMotta | BioPharma Dive
    Image attribution tooltip

    Fujifilm to invest $200M in cell therapy production

    The funds are meant to boost Fujifilm’s capacity to manufacture cell therapies, a market it expects to grow substantially in the coming years.

    By Dec. 6, 2023
  • White flags bearing Novo Nordisk's logo are seen against a blue sky.
    Image attribution tooltip
    Courtesy of Novo Nordisk
    Image attribution tooltip

    Novo to expand French plant in GLP-1 production push

    The planned $2.3 billion investment follows an earlier $6 billion commitment to expand manufacturing for drugs like its in-demand medicine Wegovy.

    By Nov. 27, 2023
  • Young woman working in lab
    Image attribution tooltip
    LaylaBird via Getty Images
    Image attribution tooltip
    Sponsored by Cognizant

    Data infrastructure excellence changing the shape of biopharma manufacturing

    Biopharma companies capture data across a variety of different fronts and, so this data must be managed effectively in order to unlock business efficiencies and drive improvements.

    Nov. 20, 2023
  • An injector of Eli Lilly's weight loss treatment Zepbound is seen against a neutral background.
    Image attribution tooltip
    Courtesy of Eli Lilly
    Image attribution tooltip

    Lilly plans new $2.5B manufacturing plant as obesity drug demand ramps up

    Following the approval of Zepbound, Lilly is adding capacity to avert shortages and restricted access.

    By Nov. 17, 2023
  • Vaccine vials on a production line in a pharmaceutical factory.
    Image attribution tooltip
    luza studios via Getty Images
    Image attribution tooltip
    Sponsored by Emergent

    3 things manufacturers need to know about the new Annex 1 revision

    As biopharmaceutical organizations around the globe adjust to the new guidelines, Baroni shared insights on three things they need to know about Annex 1.

    Nov. 13, 2023
  • White flags bearing Novo Nordisk's logo are seen against a blue sky.
    Image attribution tooltip
    Courtesy of Novo Nordisk
    Image attribution tooltip
    Obesity drugs

    Novo takes aim at obesity drug shortages with $6B manufacturing plan

    The maker of Wegovy and Ozempic plans to expand production in its home country of Denmark to help meet surging demand for the GLP-1 drugs.

    By Nov. 10, 2023
  • PHCbi appliances.
    Image attribution tooltip
    Permission granted by PHC Corporation of North America
    Image attribution tooltip
    Sponsored by PHC Corporation of North America

    Futureproofing your lab to meet tomorrow’s sustainability standards

    Industry-leading cold storage manufacturers are engineering new solutions that can reliably meet performance benchmarks while consuming far less energy than yesterday’s ULT and laboratory-grade freezers.

    Nov. 6, 2023
  • This image depicts the podcast series cover image for NTT Data's BioPharma Dive series, "Secure Innovation: How Life Sciences and Pharmaceutical Companies Can Safely Seize Opportunity"
    Image attribution tooltip
    Alyssa Sierra/BioPharma Dive
    Image attribution tooltip
    Sponsored by NTT DATA

    [Podcast] Secure Innovation: How Life Sciences and Pharmaceutical Companies Can Safely Seize Opportunity

    This podcast series explores how life sciences companies can bolster their cybersecurity while growing their business.

    Updated Dec. 19, 2023
  • A 3D illustration of cancer cells.
    Image attribution tooltip
    Dr_Microbe via Getty Images
    Image attribution tooltip

    With $56M, a Mayo Clinic-backed startup takes aim at radiopharmaceutical roadblocks

    Nucleus RadioPharma, a contract developer and manufacturer, is expanding at a time when investment is pouring into the radiopharmaceutical drug field.

    By Oct. 17, 2023
  • The logo of German pharmaceuticals and chemicals giant Bayer stands over Bayer corporate offices on September 14, 2016 in Berlin, Germany.
    Image attribution tooltip
    Sean Gallup via Getty Images
    Image attribution tooltip

    Bayer opens California plant to make cell therapies

    The pharma plans for the new Berkeley facility to produce clinical, and potentially commercial, supplies of a Parkinson’s disease cell therapy being tested by its subsidiary BlueRock. 

    By Oct. 10, 2023
  • Woman after chemotherapy visiting doctor in hospital
    Image attribution tooltip
    Permission granted by MMIT
    Image attribution tooltip
    Sponsored by MMIT

    Using real-world data to improve patient access to oncology therapies

    Oncology manufacturers can improve access by using claims, labs, pathway and policy data to address misalignment. 

    By Carolyn Zele, Solution Consulting Advisor, MMIT • Oct. 9, 2023
  • A building framed through tree foliage is seen with a sign that reads "Lilly."
    Image attribution tooltip

    Kris Tripplaar/Sipa/Newscom

    Image attribution tooltip

    Lilly eczema drug turned back by FDA over manufacturing

    The rejection of lebrikizumab is Lilly’s second for an immunology drug this year, following a complete response letter for mirikizumab in April. 

    By Oct. 2, 2023
  • A chemist in the lab working on a chemical experiment
    Image attribution tooltip
    Permission granted by BioPharmaSpec
    Image attribution tooltip
    Sponsored by BioPharmaSpec

    Process-related impurities: Looking beyond the API for safer biotherapeutics

    De-risk your biomanufacturing- an essential mini-guide to detection and quantitation of residuals.

    Oct. 2, 2023
  • A man looks at a glass test tube in a lab, with beakers and additional tubes on a surface in front of him. Overlaid on the image are strands of double-helix DNA and chemistry diagrams.
    Image attribution tooltip
    metamorworks via Getty Images
    Image attribution tooltip

    Novo Nordisk parent backs cell therapy manufacturing facility

    The Novo Nordisk Foundation’s planned manufacturing facility will help both private companies and academic researchers develop new cell therapies.

    By Sept. 21, 2023